11/11/2014 – Biogen
Issued: 11/10/2014
Biogen, BIIB:
1. As noted in recent live meetings continued daily closes above $317 in Biogen are the stronger position and indicate a test/attempt at $331 (or higher) during the week of Nov. 10.
2. Therefore, for aggressive traders Biogen is a ‘Buy’ at current prices (current price $325.35). Ordinary traders can enter long upon a daily close above $25.10.
3. Partial long position exit should be taken at/near $328, another portion at/near $331. Any remaining long position be held for the possibility of higher prices to be messaged in a subsequent update.
4. Protective sell stops should be placed below $317. This stop will be moved higher as the market continues to confirm.
David Williams
Issued: 11/11/2014
Biogen, BIIB:
1. Our previous Mon., Nov. 10 report indicated Biogen as a ‘Buy‘ at the then current price of $325.35, or higher. The main upside target was at/near $331.00 (or higher) due during this week, the week of Nov. 10.
2. Initial long position exits were instructed to be taken at/near $328.00 Today’s (Tues., Nov. 11) session completed the $328.00 upside target (today’s session high, $329.88, so far). Further long position exit should be taken at/near the $331.00 upside target noted in the original update.
3. Our protective sell stop has been raised to $324.00. This stop will continue to be moved higher as the market continues to confirm.
David Williams
Issued: 11/11/2014
Biogen, BIIB:
1. Our previous Mon., Nov. 10 report indicated Biogen as a ‘Buy‘ at the then current price of $325.35, or higher. The main upside target was at/near $331.00 (or higher) due during this week, the week of Nov. 10.
2. Initial long position exits were taken at $328.00 today and remaining long positions were exited at/near the $331.00 final upside target noted in the original update (today’s session high, $330.37).
3. For those who did not exit at/near $331.00 in today’s session, the protective stop was hit at $324.00, resulting in a likely overall gain on the entire position. Will message any further entry or indication.
David Williams
CFTC RULE 4.41 – HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.